Targeting mitogen-activated protein kinase 6-driven oncogenic signaling in lung adenocarcinoma: Insights from protein-ligand dynamics, conformational landscapes, and MM/PBSA binding energetics.
Abstract
The atypical mitogen-activated protein kinase 6 (MAPK6), commonly referred to as ERK3, is a member of the MAP kinase family, plays a vital role in both the initiation and progression of cancer promotes the growth of tumors. Here, we used a multi-faceted in silico approach to identify potential phytochemical inhibitors of MAPK6. Using a curated collection of compounds from the IMPPAT 2.0 database, we utilized structure-based virtual screening methods to select several candidate phytochemicals. We then evaluated three selected candidates (Glabrocoumarin, Candidine, and Artonin P) using density functional theory (DFT) analysis and essential dynamics to assess their stability properties and interactions with the MAPK6 active site. To further support our assessment of the candidate phytochemicals' potential as MAPK6 inhibitors, we ran extended 1000 ns MD simulations to confirm conformational stability and the persistence of key intermolecular interactions. Overall, our analyses revealed strong binding interactions between the selected candidates and MAPK6, along with stable accommodations in the MAPK6 active site. Consequently, our analyses indicate that several plant-derived molecular scaffolds may be used as inhibitors of MAPK6. Additionally, our analyses support using computational approaches to evaluate the potential efficacy of phytochemicals as MAPK6 inhibitors. Ultimately, our analyses suggest that further experimental evaluation of the selected candidates will help identify effective therapeutics for treating lung cancer.